Testosterone Replacement Therapy: A Complete Educational Guide

Testosterone replacement therapy (TRT) is a physician-prescribed treatment that restores testosterone to a normal physiological range in men who have been clinically diagnosed with testosterone deficiency, also called hypogonadism. It is not an over-the-counter supplement, a lifestyle enhancement product, or something a person self-diagnoses from symptoms alone — it is a prescription medical therapy governed by published clinical guidelines, lab-based diagnostic criteria, and ongoing monitoring requirements.

This guide is educational. It is not medical advice, and nothing here should be read as a recommendation to start, stop, or adjust any treatment. Every decision about whether TRT is appropriate, and how it should be structured, belongs to you and your own licensed physician.

Why this page exists

Search for "TRT" online and you'll find two extremes: alarmist coverage still anchored to a decade-old FDA warning, and marketing from clinics that talk about testosterone the way a supplement brand talks about a multivitamin. Both miss what TRT actually is — a regulated prescription medication with real benefits for a specific, diagnosable condition, real tradeoffs that deserve to be understood before starting, and a monitoring requirement that doesn't end once the first prescription is filled. This page exists to lay out what the published guidelines and clinical trials actually say, in plain language, without either exaggerating the risk or selling the benefit.

What TRT actually treats

Testosterone is the primary male sex hormone, produced mainly in the testes under signaling from the pituitary gland. Levels naturally decline with age, but a gradual decline is not the same as a diagnosable deficiency. Hypogonadism refers to a specific clinical picture: consistently low testosterone on repeat blood testing, combined with symptoms and signs that track with low testosterone — reduced sexual desire, fewer spontaneous erections, fatigue, loss of muscle mass and strength, and in some cases infertility (Mayo Clinic; Cleveland Clinic).

Many of these symptoms overlap with other conditions — sleep apnea, thyroid disorders, depression, medication side effects — which is exactly why guidelines insist on lab confirmation rather than symptom checklists alone.

Who the guidelines say TRT is for

The two major U.S. clinical guidelines on this topic — the Endocrine Society's 2018 Clinical Practice Guideline and the American Urological Association's (AUA) 2018 Testosterone Deficiency Guideline — converge on a similar standard: a diagnosis requires unequivocally and consistently low testosterone on at least two separate morning blood draws, together with signs and symptoms consistent with deficiency (Endocrine Society; AUA).

That two-step requirement exists because testosterone naturally fluctuates through the day and can dip temporarily due to illness, poor sleep, or acute stress. A single low draw is not enough to build a diagnosis on — the guidelines exist in part to prevent treatment being started on noise rather than signal. For a closer look at how the diagnostic sequence actually runs in a clinician's office, see how TRT works.

What treatment involves once it starts

If a physician confirms a diagnosis and determines TRT is appropriate, treatment isn't a single decision — it's an ongoing relationship between the patient, the prescriber, and periodic bloodwork. The Endocrine Society guideline specifically recommends that physicians monitor patients on testosterone therapy using a standardized plan: tracking symptom response, checking for adverse effects and treatment adherence, rechecking testosterone and hematocrit (red blood cell concentration) levels, and evaluating prostate-related risk markers, especially during the first year of treatment (Endocrine Society).

This monitoring cadence is a structural feature of legitimate TRT care, not an optional add-on. We break down the logic behind why levels get rechecked, and what a physician is actually watching for, in protocol literacy basics.

The estrogen side of the equation

Testosterone doesn't act alone in the body — a portion of it is continuously converted into estradiol, a form of estrogen, by an enzyme called aromatase. That conversion is a normal and necessary process: estrogen in men plays a documented role in bone density maintenance and cardiovascular regulation, not just in women's physiology. When testosterone therapy raises circulating testosterone, it can also raise estradiol, and in some men that shift produces its own symptoms that need to be tracked and, if warranted, managed by the prescribing physician. This is a real and well-studied part of TRT that deserves its own explanation — see estrogen management on TRT.

Fertility is part of the conversation, not a footnote

Because exogenous testosterone suppresses the hypothalamic-pituitary-gonadal signaling that normally drives natural testosterone and sperm production, TRT can significantly reduce sperm counts, in some cases within months of starting. This is a well-documented physiological tradeoff, not a rare side effect, and it's one reason fertility goals belong in the initial conversation with a prescriber rather than being discovered later.

The cardiovascular question, revisited

For years, TRT carried a boxed warning about cardiovascular risk, added by the FDA in 2015 out of caution following early observational signals (FDA). That question was directly tested in the TRAVERSE trial, a large randomized, placebo-controlled study of more than 5,000 men with hypogonadism and existing or elevated cardiovascular risk. The trial found testosterone therapy was noninferior to placebo for major adverse cardiac events — 7.0% of the testosterone group experienced a first major cardiovascular event versus 7.3% of the placebo group (Lincoff et al., NEJM). Based substantially on that trial, the FDA removed the cardiovascular boxed warning from testosterone product labels in 2025 — while adding a new warning about blood pressure increases and noting other findings from the trial, including a higher rate of non-fatal arrhythmias and blood clots in the testosterone group. The picture is more nuanced than either "TRT is dangerous" or "TRT is risk-free," which is precisely why ongoing monitoring, not a one-time prescription, is the guideline standard.

Finding the right physician

TRT sits at the intersection of endocrinology and urology, and not every prescriber approaches it with the same rigor. A physician who orders confirmatory labs, discusses fertility and estrogen implications up front, and commits to a real monitoring schedule is doing something structurally different from a service that prescribes off a single symptom questionnaire. We cover what to actually look for — and how to verify a physician's credentials — in finding a TRT-literate physician.

Separating the science from the noise

TRT is one of the more mythologized areas of men's health, pulled between overcautious fear (leftover from the 2015 warning era) and overpromising marketing (from clinics selling it as a universal fix for aging). Neither extreme reflects the actual evidence base. We go through the most persistent claims — on prostate cancer, heart risk, fertility, and "natural" alternatives — against the published research in TRT myths vs. the research.

Everything on this page is educational. It does not diagnose, prescribe, or recommend a specific treatment path. Testosterone is a prescription medication in the United States, and any decision to start, adjust, or stop it belongs to you and your own licensed physician.

Why "educational, not prescriptive" is the right frame

It's worth being explicit about what this site is and isn't. Adonis TRT Club is an educational and advisory resource — it explains how TRT works, what the research shows, and what questions to bring to a physician. It does not diagnose, does not prescribe, and does not sell testosterone or any controlled substance. Every clinical decision described on this page — whether to test, whether to treat, how to monitor, whether to adjust — belongs to you and a licensed physician who has your actual labs and history in front of them. That boundary isn't a legal formality; it reflects the reality that testosterone deficiency, and its treatment, can't be responsibly assessed from a web page.

How the pieces of this guide fit together

The five articles linked throughout this page each take one part of the TRT picture and go deeper than a single pillar page reasonably can. How TRT works walks through the diagnostic sequence and the hormonal feedback loop testosterone therapy interacts with. Estrogen management on TRT explains why aromatization matters and what the research says about monitoring it. Finding a TRT-literate physician gives you a concrete way to evaluate a prescriber before committing to care. TRT myths vs. the research checks the most common claims — good and bad — against the published evidence. And protocol literacy basics explains the general logic of why monitoring happens on a recurring schedule, a concept that applies to peptide protocols as much as it does to TRT.

TRT can be a legitimate, well-studied treatment for a clearly defined medical condition. Whether it's appropriate for any individual person is a clinical judgment — one that depends on lab-confirmed diagnosis, personal risk factors, fertility goals, and ongoing monitoring, made in partnership with a physician who takes all of it seriously.